Cormorant Asset Management Cut By $16.50 Million Its Juno Therapeutics (JUNO) Holding; TripAdvisor, Inc. (TRIP) Covered By 0 Bullish Analysts Last Week

January 13, 2018 - By Peter Erickson

Cormorant Asset Management Llc decreased Juno Therapeutics Inc (JUNO) stake by 50% reported in 2017Q3 SEC filing. Cormorant Asset Management Llc sold 375,000 shares as Juno Therapeutics Inc (JUNO)’s stock rose 2.20%. The Cormorant Asset Management Llc holds 375,000 shares with $16.82 million value, down from 750,000 last quarter. Juno Therapeutics Inc now has $5.57B valuation. The stock decreased 2.68% or $1.34 during the last trading session, reaching $48.75. About 1.51 million shares traded. Juno Therapeutics, Inc. (NASDAQ:JUNO) has declined 39.85% since January 13, 2017 and is downtrending. It has underperformed by 56.55% the S&P500.

Among 30 analysts covering TripAdvisor LLC (NASDAQ:TRIP), 0 have Buy rating, 7 Sell and 23 Hold. Therefore 0 are positive. TripAdvisor LLC had 78 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Sell” rating by Jefferies on Thursday, September 28. The stock of TripAdvisor, Inc. (NASDAQ:TRIP) earned “Sell” rating by Bank of America on Wednesday, August 9. The stock has “Neutral” rating by UBS on Friday, November 6. The firm earned “Sector Perform” rating on Friday, February 12 by RBC Capital Markets. Cowen & Co upgraded the stock to “Market Perform” rating in Wednesday, July 19 report. On Thursday, August 31 the stock rating was maintained by KeyBanc Capital Markets with “Hold”. The firm has “Sell” rating given on Thursday, September 28 by Needham. The firm has “Buy” rating given on Friday, July 24 by Deutsche Bank. The firm has “Neutral” rating by Credit Suisse given on Wednesday, January 11. The firm earned “Equal-Weight” rating on Wednesday, November 8 by Barclays Capital. See TripAdvisor, Inc. (NASDAQ:TRIP) latest ratings:

27/11/2017 Broker: Cowen & Co Old Rating: Market Perform New Rating: Market Perform Old Target: $30 New Target: $40 Maintain
13/11/2017 Broker: RBC Capital Markets Rating: Hold New Target: $34.0 Maintain
08/11/2017 Broker: Hilliard Lyons Rating: Hold Downgrade
08/11/2017 Broker: Wells Fargo Rating: Hold New Target: $33.0 Maintain
07/11/2017 Broker: Susquehanna Rating: Hold New Target: $28.0
08/11/2017 Broker: Barclays Capital Rating: Equal-Weight Old Target: $45 New Target: $35 Maintain
08/11/2017 Broker: UBS Rating: Neutral Old Target: $43 Maintain
08/11/2017 Broker: Stifel Nicolaus Rating: Hold Old Target: $40 New Target: $32 Maintain
02/11/2017 Broker: RBC Capital Markets Rating: Hold New Target: $38.0 Maintain
24/10/2017 Broker: Deutsche Bank Rating: Hold Old Target: $40 New Target: $37 Maintain

Since August 17, 2017, it had 0 buys, and 2 sales for $514,535 activity. On Monday, December 18 Nishar Dipchand sold $11,937 worth of TripAdvisor, Inc. (NASDAQ:TRIP) or 346 shares. $502,598 worth of stock was sold by Halpin Dermot on Thursday, August 17.

The stock increased 3.57% or $1.26 during the last trading session, reaching $36.54. About 4.42 million shares traded or 16.46% up from the average. TripAdvisor, Inc. (NASDAQ:TRIP) has declined 30.31% since January 13, 2017 and is downtrending. It has underperformed by 47.01% the S&P500.

Investors sentiment increased to 0.94 in Q3 2017. Its up 0.15, from 0.79 in 2017Q2. It is positive, as 37 investors sold TripAdvisor, Inc. shares while 108 reduced holdings. 52 funds opened positions while 84 raised stakes. 120.15 million shares or 5.11% more from 114.31 million shares in 2017Q2 were reported. Pennsylvania-based Pnc Serv Incorporated has invested 0% in TripAdvisor, Inc. (NASDAQ:TRIP). Baillie Gifford & Commerce holds 0.22% in TripAdvisor, Inc. (NASDAQ:TRIP) or 4.19M shares. Texas Permanent School Fund has 30,019 shares for 0.02% of their portfolio. Wolverine Asset Ltd Liability has 0% invested in TripAdvisor, Inc. (NASDAQ:TRIP) for 2,703 shares. Swiss Bancshares invested in 0.02% or 427,500 shares. Panagora Asset Mgmt stated it has 0% of its portfolio in TripAdvisor, Inc. (NASDAQ:TRIP). Lourd Limited Company has invested 0.03% in TripAdvisor, Inc. (NASDAQ:TRIP). Whittier Of Nevada Inc holds 0% of its portfolio in TripAdvisor, Inc. (NASDAQ:TRIP) for 284 shares. Ameritas Prtnrs holds 0.01% or 2,731 shares in its portfolio. Group Inc One Trading Limited Partnership has invested 0.01% in TripAdvisor, Inc. (NASDAQ:TRIP). Sumitomo Mitsui Trust Inc stated it has 324,069 shares. Daiwa Gru Inc reported 46,906 shares. Moreover, Veritable L P has 0.01% invested in TripAdvisor, Inc. (NASDAQ:TRIP) for 5,964 shares. Pub Sector Pension Board reported 5,744 shares or 0% of all its holdings. Kentucky Retirement Systems reported 6,781 shares stake.

TripAdvisor, Inc. operates as an online travel company. The company has market cap of $5.08 billion. The firm operates through two divisions, Hotel and Non-Hotel. It has a 78.58 P/E ratio. The Company’s travel platform aggregates reviews and opinions of members about destinations, accommodations, activities and attractions, and restaurants, which enables users to research and plan their travel experiences, as well as book hotels, flights, cruises, vacation rentals, activities and attractions, and restaurant reservations.

Investors sentiment increased to 1.44 in 2017 Q3. Its up 0.11, from 1.33 in 2017Q2. It increased, as 26 investors sold JUNO shares while 46 reduced holdings. 51 funds opened positions while 53 raised stakes. 66.13 million shares or 23.59% more from 53.50 million shares in 2017Q2 were reported. Da Davidson & invested in 210,373 shares. Federated Invsts Pa holds 0% of its portfolio in Juno Therapeutics, Inc. (NASDAQ:JUNO) for 23,434 shares. Royal National Bank & Trust Of Canada accumulated 2,429 shares or 0% of the stock. Employees Retirement Association Of Colorado reported 10,810 shares or 0% of all its holdings. Credit Suisse Ag holds 0.01% of its portfolio in Juno Therapeutics, Inc. (NASDAQ:JUNO) for 197,942 shares. Credit Agricole S A, a France-based fund reported 30,800 shares. Capital Int Investors owns 5.71 million shares. 32,062 are held by Evercore Wealth Mngmt Ltd Limited Liability Company. Raymond James Fincl Service Advsrs Incorporated reported 11,365 shares. Citigroup has 0% invested in Juno Therapeutics, Inc. (NASDAQ:JUNO). Partner Fund Mgmt Lp holds 1.45M shares or 1.28% of its portfolio. Canada Pension Plan Invest Board owns 146,700 shares. California Pub Employees Retirement reported 73,100 shares or 0% of all its holdings. Hbk Investments Limited Partnership accumulated 5,960 shares. 49,000 were reported by Art Advisors Lc.

Analysts await Juno Therapeutics, Inc. (NASDAQ:JUNO) to report earnings on March, 7. They expect $-1.02 EPS, down 54.55% or $0.36 from last year’s $-0.66 per share. After $-1.12 actual EPS reported by Juno Therapeutics, Inc. for the previous quarter, Wall Street now forecasts -8.93% EPS growth.

Among 18 analysts covering Juno Therapeutics Inc (NASDAQ:JUNO), 10 have Buy rating, 1 Sell and 7 Hold. Therefore 56% are positive. Juno Therapeutics Inc had 46 analyst reports since July 22, 2015 according to SRatingsIntel. Wedbush initiated Juno Therapeutics, Inc. (NASDAQ:JUNO) on Thursday, February 2 with “Neutral” rating. Standpoint Research upgraded Juno Therapeutics, Inc. (NASDAQ:JUNO) on Tuesday, December 15 to “Buy” rating. The firm earned “Buy” rating on Thursday, November 2 by Wedbush. The stock of Juno Therapeutics, Inc. (NASDAQ:JUNO) earned “Buy” rating by Citigroup on Thursday, February 25. The firm earned “Mkt Perform” rating on Wednesday, November 23 by FBR Capital. The rating was initiated by Wells Fargo on Wednesday, February 22 with “Outperform”. Maxim Group maintained the shares of JUNO in report on Friday, August 5 with “Buy” rating. FBR Capital maintained Juno Therapeutics, Inc. (NASDAQ:JUNO) on Friday, July 8 with “Outperform” rating. As per Friday, November 25, the company rating was downgraded by Suntrust Robinson. BTIG Research downgraded the shares of JUNO in report on Thursday, June 8 to “Sell” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>